biote Corp. (BTMD)
USD 3.53
(3.37%)
USD 3.53
(3.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 185.36 Million USD | 12.37% |
| 2022 | 164.95 Million USD | 18.34% |
| 2021 | 139.39 Million USD | 19.58% |
| 2020 | 116.56 Million USD | 5.99% |
| 2019 | 109.97 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 49.16 Million USD | 5.05% |
| 2024 Q1 | 46.8 Million USD | 2.41% |
| 2023 Q2 | 49.25 Million USD | 9.84% |
| 2023 FY | 185.36 Million USD | 12.37% |
| 2023 Q3 | 45.55 Million USD | -7.51% |
| 2023 Q1 | 44.84 Million USD | 0.8% |
| 2023 Q4 | 45.7 Million USD | 0.32% |
| 2022 Q2 | 41.35 Million USD | 11.35% |
| 2022 Q1 | 37.14 Million USD | -1.05% |
| 2022 FY | 164.95 Million USD | 18.34% |
| 2022 Q4 | 44.48 Million USD | 5.99% |
| 2022 Q3 | 41.97 Million USD | 1.48% |
| 2021 Q4 | 37.53 Million USD | 5.54% |
| 2021 Q2 | 34.75 Million USD | 10.17% |
| 2021 Q1 | 31.54 Million USD | 2.31% |
| 2021 FY | 139.39 Million USD | 19.58% |
| 2021 Q3 | 35.56 Million USD | 2.35% |
| 2020 Q4 | 30.83 Million USD | 0.0% |
| 2020 FY | 116.56 Million USD | 5.99% |
| 2019 FY | 109.97 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 93.671% |
| Addus HomeCare Corporation | 1.05 Billion USD | 82.491% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 5.389% |
| Amedisys, Inc. | 2.23 Billion USD | 91.712% |
| American Oncology Network, Inc. | 1.27 Billion USD | 85.51% |
| Astrana Health, Inc. | 1.38 Billion USD | 86.633% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 90.22% |
| IMAC Holdings, Inc. | 5.19 Million USD | -3466.673% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -491.379% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 90.823% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 70.309% |
| The Ensign Group, Inc. | 3.72 Billion USD | 95.03% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 88.91% |
| InnovAge Holding Corp. | 763.85 Million USD | 75.734% |
| Assure Holdings Corp. | 255 Thousand USD | -72590.196% |
| The Joint Corp. | 117.69 Million USD | -57.49% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 82.441% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -1689.445% |
| ModivCare Inc. | 2.75 Billion USD | 93.263% |
| NewGenIvf Group Limited | 5.13 Million USD | -3508.927% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -1374.385% |
| Option Care Health, Inc. | 4.3 Billion USD | 95.692% |
| P3 Health Partners Inc. | 1.26 Billion USD | 85.363% |
| P3 Health Partners Inc. | 1.26 Billion USD | 85.363% |
| The Pennant Group, Inc. | 544.89 Million USD | 65.982% |
| Surgery Partners, Inc. | 2.74 Billion USD | 93.243% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -3260.928% |
| Talkspace, Inc. | 150.04 Million USD | -23.536% |
| Talkspace, Inc. | 150.04 Million USD | -23.536% |
| The Oncology Institute, Inc. | 324.23 Million USD | 42.832% |
| The Oncology Institute, Inc. | 324.23 Million USD | 42.832% |